Abstract:Objective
Long interspersed nuclear element 1 (LINE‐1) encodes 2 proteins, the RNA binding protein p40 and endonuclease and reverse transcriptase (open‐reading frame 2p [ORF2p]), which are both required for LINE‐1 to retrotranspose. In cells expressing LINE‐1, these proteins assemble with LINE‐1 RNA and additional RNA binding proteins, some of which are well‐known autoantigens in patients with systemic lupus erythematosus (SLE). This study was undertaken to investigate whether SLE patients also produce autoant… Show more
“…In systemic lupus erythematosus (SLE), anti-double-stranded DNA (anti-dsDNA) autoantibodies are features of active disease and are particularly associated with lupus nephritis, and the identity of the self or foreign antigens that "break tolerance" (leading to anti-dsDNA and other autoantibody specificities) has been a topic of extensive study. In that context, the study described by Carter et al (1), in which they identified reactivity of sera from SLE patients using the 40-kd protein product of the first open-reading frame (ORF) of the human long interspersed nuclear element 1 (LINE-1) retroelement, is of great interest.…”
Section: Reactivity Of Igg With the P40 Protein Encoded By The Long Imentioning
confidence: 99%
“…In addition, LINE‐1 nucleic acid can induce type I interferon (IFN), a key pathogenic mediator in SLE . In that regard, the data from Carter and colleagues’ study support the notion of a relationship between high levels of IgG anti‐p40 and a high type I IFN score . The RNP particles that contain LINE‐1 p40, associated LINE‐1 RNA, and DNA, as well as a multitude of proteins that have been implicated as autoantigens in systemic autoimmune diseases , should be priority targets for detailed study of the mechanisms through which the viral remnants in our genomes might act as initiators of autoimmunity.…”
“…In systemic lupus erythematosus (SLE), anti-double-stranded DNA (anti-dsDNA) autoantibodies are features of active disease and are particularly associated with lupus nephritis, and the identity of the self or foreign antigens that "break tolerance" (leading to anti-dsDNA and other autoantibody specificities) has been a topic of extensive study. In that context, the study described by Carter et al (1), in which they identified reactivity of sera from SLE patients using the 40-kd protein product of the first open-reading frame (ORF) of the human long interspersed nuclear element 1 (LINE-1) retroelement, is of great interest.…”
Section: Reactivity Of Igg With the P40 Protein Encoded By The Long Imentioning
confidence: 99%
“…In addition, LINE‐1 nucleic acid can induce type I interferon (IFN), a key pathogenic mediator in SLE . In that regard, the data from Carter and colleagues’ study support the notion of a relationship between high levels of IgG anti‐p40 and a high type I IFN score . The RNP particles that contain LINE‐1 p40, associated LINE‐1 RNA, and DNA, as well as a multitude of proteins that have been implicated as autoantigens in systemic autoimmune diseases , should be priority targets for detailed study of the mechanisms through which the viral remnants in our genomes might act as initiators of autoimmunity.…”
“…Essentially all patients with SLE have IgG autoantibodies against ORF1p [ 107 , 108 ], which correlate with disease activity measured by the SLE disease activity index (SLEDAI), the presence of lupus nephritis, complement consumption, increased anti-dsDNA, and higher type I IFN activity [ 107 ]. Importantly, there anti-ORF1p autoantibodies do not represent anti-DNA reactivity, as free dsDNA did not compete (while free ORF1p did), DNase treatment did not affect them (while it eliminated anti-dsDNA reactivity), and ORF1p was recognized even when mixed with whole cell lysates.…”
Section: How L1 Retrotransposons May Trigger Ifn-positive Slementioning
confidence: 99%
“…As we recently demonstrated, the titers of IgG autoantibodies against L1 ORF1p correlate significantly with disease phenotypes, SLEDAI, markers of disease activity, and IFN score [ 107 ]. These autoantibodies could conceivably aid in the diagnosis and prognosis of the disease, perhaps guiding which endotype of SLE an individual patient has and, hence, which treatment regimen might be most effective.…”
Section: How L1 Retrotransposons May Trigger Ifn-positive Slementioning
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. While its etiology remains elusive, current understanding suggests a multifactorial process with contributions by genetic, immunologic, hormonal, and environmental factors. A hypothesis that combines several of these factors proposes that genomic elements, the L1 retrotransposons, are instrumental in SLE pathogenesis. L1 retroelements are transcriptionally activated in SLE and produce two proteins, ORF1p and ORF2p, which are immunogenic and can drive type I interferon (IFN) production by producing DNA species that activate cytosolic DNA sensors. In addition, these two proteins reside in RNA-rich macromolecular assemblies that also contain well-known SLE autoantigens like Ro60. We surmise that cells expressing L1 will exhibit all the hallmarks of cells infected by a virus, resulting in a cellular and humoral immune response similar to those in chronic viral infections. However, unlike exogenous viruses, L1 retroelements cannot be eliminated from the host genome. Hence, dysregulated L1 will cause a chronic, but perhaps episodic, challenge for the immune system. The clinical and immunological features of SLE can be at least partly explained by this model. Here we review the support for, and the gaps in, this hypothesis of SLE and its potential for new diagnostic, prognostic, and therapeutic options in SLE.
“…Various assays have been established to detect RT activity in cells, whether deriving from L1 ORF2p or HERV pol genes [175][176][177]. Using RT-qPCR to assay changes in expression of interferon-stimulated genes may also reveal autoinflammatory effects of retrotransposon misregulation, as described above for AGS and some other autoimmune conditions [137,[178][179][180].…”
LINE1 retrotransposons are mobile DNA elements that copy and paste themselves into new sites in the genome. To ensure their evolutionary success, heritable new LINE-1 insertions accumulate in cells that can transmit genetic information to the next generation (i.e., germ cells and embryonic stem cells). It is our hypothesis that LINE1 retrotransposons, insertional mutagens that affect expression of genes, may be causal agents of early miscarriage in humans. The cell has evolved various defenses restricting retrotransposition-caused mutation, but these are occasionally relaxed in certain somatic cell types, including those of the early embryo. We predict that reduced suppression of L1s in germ cells or early-stage embryos may lead to excessive genome mutation by retrotransposon insertion, or to the induction of an inflammatory response or apoptosis due to increased expression of L1-derived nucleic acids and proteins, and so disrupt gene function important for embryogenesis. If correct, a novel threat to normal human development is revealed, and reverse transcriptase therapy could be one future strategy for controlling this cause of embryonic damage in patients with recurrent miscarriages.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.